PennyPerformers.com: "Penny Stocks that Perform" picks are: ABTG, CYXI, EMDY, GLOB, IXSBF, YTBLA

Nov 17, 2008 (M2 PRESSWIRE via COMTEX) -- YTBLA | Quote | Chart | News | PowerRating -- Pennyperformers.com "Penny Stocks that Perform" picks are: Ambient Corporation (OTCBB: ABTG), China Yingxia International, Inc. (OTCBB: CYXI), Emerald Dairy, Inc. (OTCBB: EMDY), Global Med Technologies(R), Inc. (OTCBB: GLOB), InNexus Biotechnology Inc., (OTCBB: IXSBF/TSX VENTURE: IXS), 2008 YTB International, Inc. (OTCBB: YTBLA)...and Proudly Introducing Proprietary Push Technology (PPT).

The Newest and Revolutionary Technology for Increasing Investor Visability.

REAL Awareness for REAL Companies.

Click below for a full demonstration.

http://newmediaadvisors.info/newmedia.swf

Sign-up for our FREE Stock Alerts AND NEWSLETTER at www.pennyperformers.com

Nov 17, 2008 -- Ambient Corporation (OTCBB: ABTG | Quote | Chart | News | PowerRating) announced today financial results for its third quarter period ended September 30, 2008. Highlights of the quarter include record three-month revenues of $3,639,234 and corresponding nine-month revenues of $4,450,099.

Third quarter revenues primarily resulted from the continuing success and delivery of products and services related to an April 2008 contract to supply one of the largest electric power companies in the United States with proprietary smart grid communications equipment.

Ambient enthusiastically continues to support utilities that share the vision of achieving the long-term goals of a twenty-first century distribution grid, that enables energy efficiencies as well as intelligent consumer choices such as real-time pricing and demand response.

"Our third quarter financial results continue to demonstrate our ability to deliver on our commitments to those utilities committed to addressing the energy crisis and the concerns of the environment," stated John J. Joyce, President and CEO. "We continue to execute according to our operational plan and anticipate a successful completion of our current initiatives. Our quarterly revenues show our ability to address the wide array of specific applications and integration needs facing utilities looking to modernize their infrastructure. Ambient consistently develops technology offerings and features focused on a single fully integrated, two-way communications platform for all utility needs, and we believe our focus and success will drive positive revenue growth for Ambient."

Operations Highlights -- Third Quarter:

Revenues - Total revenues for the nine and three-months ended September 30, 2008 were $4,450,099 and $3,639,234 respectively. Revenues for the corresponding periods in 2007 were $1,969,514 and $33,330 respectively. Revenues for the 2008 period were attributable to the sale of equipment and software, related network design, and installation services relating to our most recent purchase order. Revenues for the 2007 period were attributable to the sale of equipment, software, related network design, and installation services that we provided in connection with a purchase order that we received in September 2006.

Cost of Goods Sold and Gross Profit - Cost of goods sold for the nine and three-months ended September 30, 2008, were $3,781,648 and $2,833,148, respectively, compared to $1,493,110 and $80,881 during the corresponding periods in 2007. During the nine and three-months ended September 30, 2008, cost of goods sold included an inventory reserve of $314,810 and $27,989 for excess, obsolete, and surplus inventory resulting from the transition from first to second generation technology. For the nine-months ended September 30, 2008, we had a gross profit of $668,451 compared to a gross profit of $476,404 for the corresponding nine-month period in 2007 and for the three-months ended September 30, 2008 we had a gross profit of $806,086 compared to a gross loss of $47,551 for the corresponding three-month period in 2007. The increase in gross profit for the three-months ended September 30, 2008, was attributable to the accelerated efforts to introduce and commercialize our Ambient Smart Grid(TM) communications platform, while we began fulfilling our most recent purchase order. Management believes that the Company will fulfill the purchase order by the end of November 2008.

A more detailed description of Ambient's business, our results of operations and financial statements are contained in the Quarterly Report on Form 10-Q filed on November 14, 2008. Ambient has sustained losses since its inception and expects to incur additional losses for the immediate future requiring the need to raise additional funds.

About Ambient Corporation

Ambient designs, develops and markets Ambient Smart Grid(TM) communications technologies and equipment. Utilizing proprietary, open standards-based technologies along with in-depth industry experience, Ambient provides utilities with solutions for creating smart grid communication platforms and technologies. Headquartered in Newton, MA, Ambient is a publicly traded company (OTCBB: ABTG).

Nov 17, 2008 -- China Yingxia International, Inc. (OTCBB: CYXI | Quote | Chart | News | PowerRating) ("China Yingxia" or "the Company"), a provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and raw cactus plants in the People's Republic of China ("PRC"), reported its financial results for the third quarter ended September 30, 2008 on Friday November 14, 2008.

Third Quarter 2008 Highlights

-- Revenue increased 112.3% year-over-year to $7.5 million -- Gross profit increased 50.9% year-over-year to $3.9 million; gross margin was 52.8% -- Operating income increased 99.4% year-over-year to $3.4 million -- Net income increased 88.0% year-over-year to $3.2 million, or $0.06 per fully diluted share -- Added 146 new franchise stores -- Shanghai Jin Ao Food Co., Ltd ("Jin Ao") subsidiary contributed 10.3% of revenues -- Appointed Fanke Kong as Vice President of Finance

"Our sales in the third quarter of 2008 more than doubled from the third quarter last year, supported by strong performance of our nutritional food segment. We have continued to shift our product mix towards nutritional food products, and were pleased to see growth more than triple in this product segment from last year," said Ms. Yingxia Jiao, CEO of China Yingxia. "During the quarter, sales from our Jin Ao subsidiary contributed 10.3% of revenues, demonstrating the potential of this acquisition to our revenue growth."

Third Quarter Fiscal Year 2008 Results

Revenue for the three months ended September 30, 2008, was $7.5 million, increasing 112.3% from $3.5 million in the same period in 2007. Sales in the cactus product segment contributed 49.3% of total revenue in the third quarter of 2008, compared to 32.1% in the corresponding quarter last year. The nutritional product segment contributed 17.7% of total revenue, compared to 11.9% in the corresponding quarter last year, increasing by 216.2% year-over- year. Revenue from the Jin Ao subsidiary represented 10.3% of total revenue in the quarter. Dietary supplements, personal care products, cosmetics and the Chichi Network Companies accounted for the remaining 22.8% of revenue.

China Yingxia also expanded its sales channels during the third quarter of 2008, adding 146 new franchise stores across China.

Gross profit was $3.9 million, up 50.9% from the same period previous year. Gross profit margin was 52.8% in the third quarter of 2008 compared to 74.3% during the same period a year ago. The high gross profit margin in the third quarter of 2007 was due to the Company growing all cactus plants in its own greenhouses, while the Company outsourced the farming of cactus plants to local farmers in the third quarter of 2008. In addition, the lower gross profit margins of Jin Ao and Chi Chi Network subsidiaries impacted total gross profit margin in the third quarter of 2008.

Operating expenses totaled $0.5 million, or 7.0% of total revenue, in the third quarter of 2008, a decrease of 41.5% from $0.9 million, or 25.5% of revenue, in the same period last year. The decrease was due to significantly lower selling, general and administrative expenses, as the Company streamlined management expenses and professional services fees, and did not pay any sales commission during 2008. The Company's research and development expenditures decreased 87.9% from the third quarter of 2007 as the Company has entered a slow research and development phase.

Operating income for the third quarter of 2008 was $3.4 million, up 99.4% from $1.7 million in the equivalent period a year ago. Operating margin was 45.8% compared to 48.7% in the third quarter of 2007.

The Company paid income taxes of $153,481 as opposed to nil in the same period last year.

Net income was $3.2 million or $0.06 per fully diluted share, an increase of 88.0% from $1.7 million or $0.04 during the corresponding period prior year. Net profit margin was 43.2% compared to 48.8% in the previous year. Fully diluted weighted average shares used to calculate earnings per share was 49.7 million in the third quarter of 2008, compared to 43.7 million in the third quarter of 2007.

Nine Months Results

For the nine months ended September 30, 2008, total sales were $16.0 million, an increase of 54.0% from the nine month period ended 2007. Gross profit for the nine months ended September 30, 2008 was $8.8 million, up 37.9% from gross profit of $6.4 million in the comparable period a year ago. Gross profit margin was 55.0% compared to 61.4% for the first nine months of 2008 and 2007, respectively. Income from operations for the period was $7.4 million, up 55.9% from $4.7 million in the first nine months of 2007. Net income for the nine months ended September 30, 2008 was $7.0 million, an increase of 48.8% from $4.7 million for the nine months ended September 30, 2007. Fully diluted earnings per share were $0.14 for the nine months ended September 30, 2008 compared to $0.13 for the nine months ended September 30, 2007. Fully diluted weighted average shares used to calculate earnings per share was 49.7 million in nine months ended September 30, 2008, up from 37.0 million in the nine months ended September 30, 2007.

Financial Condition

As of September 30, 2008, the Company had $5.4 million in cash and cash equivalents and no long-term debt outstanding. Working capital was $21.2 million as of September 30, 2008, compared to $14.8 million as of December 2007. As of September 30, 2008 the current ratio was 17:1. Total shareholder's equity amounted to $46.8 million as of September, 30 2008, compared to $36.8 million as of December 31, 2007. For the nine months ended September 30, China Yingxia's net cash flow from operating activities totaled $1.5 million. Net cash flow provided by investing activities totaled $1.8 million for the nine months ended September 30, 2008, due to the collection of short-term loans and loans to related parties.

Recent Events

In September 2008, the Company announced that its Board of Directors has approved and authorized a share repurchase program for up to $2 million of its common stock. China Yingxia will repurchase shares on the open market or through privately negotiated transactions through September 30, 2009. The repurchase program may be discontinued or expanded by the Board of Directors in the future.

Business Outlook

The slowdown in domestic consumption growth in China is expected to be milder compared to the slowdown in export or fixed investment growth. Consequently, China Yingxia plans to focus on its nutritional foods segment and the soy milk products from its Jin Ao subsidiary. The Company expects the subsidiary to contribute a larger share of net income in 2009 as the capacity utilization of the facility improves, and has started to aggressively market its soy milk products to larger supermarkets through promotional programs.

As the Company has completed the most capital intensive phase of its expansion, the current focus is on improving the efficiency of its distribution channel. Excluding Jin Ao's soy milk products, the Company's distribution model relies on the development of new franchisees. During the quarter, the Company added 146 new franchisees, bringing total to 1,419 of the targeted 1,500 by the end of fiscal 2008.

"Our franchisee-based model allows us to expand our retail presence without committing significant amounts of capital to the distribution network," said Ms. Yingxia Jiao, CEO of China Yingxia. "In addition, we have seen an increase in consumers shifting from cow's milk to soy milk especially after the incidents involving contaminated cow's milk and the timing for ramping up our soy milk promotion program is hence perfect." China Yingxia reaffirms previously issued guidance for fiscal 2008 with full year revenue of $25.9 million, and net income of $12.9 million, or $0.26 per fully diluted share.

Conference Call

China Yingxia will conduct a conference call on Tuesday, November 18, 2008, at 9:00 a.m. EST, to discuss its financial results for the third quarter of 2008. To participate in this conference call, please dial 800 688 0796, five to ten minutes prior to the conference call start time (to allow time for registration) and reference the conference ID 761 841 28. International callers should dial 617.614.4070 and use the same conference ID. A digital replay of the call will be available starting Tuesday, November 18, 2008, 11:00 a.m. EST, and ending 14 days later. To listen to the replay, please dial 888-286-8010 and enter the conference ID number 73629297. International callers should dial 617-801-6888 and enter the same conference ID number.

About China Yingxia International, Inc

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang, Peoples Republic of China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, organic rice products, raw cacti, cactus and other herbal-based supplements, cosmetics, personal care products, and Nestle products.

Nov 17, 2008 -- Emerald Dairy, Inc. (OTCBB: EMDY), today announced third quarter 2008 financial results. The Company plans to file its third quarter 2008 Form 10-Q today.

Key highlights from the third quarter 2008 include: -- Revenue increased 32.9% year over year to $11.2 million from $8.4 million in 3Q07 -- Gross profit increased 54.6% year over year to $4.7 million from $3.0 million in 3Q07

Mr. Yang Yong Shan, Chief Executive Officer of Emerald Dairy, stated, "We are glad to share today's results with our investors. During the third quarter, despite the melamine crisis, we posted strong top line growth of 32.9%, which demonstrated consumers' confidence in our products. In this quarter, we invested approximately $0.6 million in advertising, including commercials running on Chinese Central Television."

Mr. Yang continued, "We believe the recent crisis will further strengthen our market position as consumers continue to seek out quality products. We remained committed to the highest quality and look forward to increase our offerings to customers once our Hailun facility commences production in 2009."

Revenue for the third quarter of 2008 was $11.2 million, up 32.9% from $8.4 million in the third quarter of 2007. The revenue increase was primarily attributable to a 21.0% increase in average selling price and a 9.9% growth in sales volume year over year. The sales of the Company's branded milk powder products during the third quarter increased 43.7% to $9.4 million compared to the prior year's period, or 9.8% compared to the second quarter of 2008. The increase reflected consumers' continued confidence in the Company's branded products.

Gross profit increased 54.6% to $4.7 million from $3.0 million in the third quarter of 2007. Gross margin was 41.6% in the third quarter of 2008, compared to 35.8% in the prior year's period and 33.2% in the second quarter of 2008. Gross margin performance is primarily attributable to the increase in average selling price, partially offset by a 10.0% increase in the overall cost per metric ton. Overall cost per metric ton mainly reflects the cost of milk powder and subcontracting. During the third quarter of 2008, cost of milk powder per metric ton increased 15.5% to $3,209 per metric ton while cost of subcontracting decreased 11.3% to $2,016 per metric ton.

Sales from subcontracting, which represents the sale of the Company's wholesale products, was 12.1%, compared to 17.2% in the third quarter of 2007. The decrease reflected lower sales of the Company's wholesale products as a result of increased demand for its branded products. In the third quarter of 2008, wholesale products generated a gross margin of 18.3%, compared with an average gross margin of 44.8% for branded products.

Income from operations was $1.3 million, compared with $1.4 million in the third quarter of 2007. The decline was the result of a one-time non-cash non- operating expense of approximately $414,000 in liquidated damages, resulting from the late effectiveness of the Company's registration right statement. As of the nine months ended September 30, 2008, there were accrued liquidated damages of approximately $1.1 million.

The increase of 81.0% in selling expenses to $2.5 million is primarily attributable to expenditures related to advertising and marketing activities. Advertising and marketing expenditure increased to $0.6 million as the Company continues to invest in its brand to create additional product demand in anticipation of additional capacity in 2009. Administrative expenses increased 320.0% to $866,000 during the third quarter of 2008 from $206,000 in the prior year's period. The increase is attributable to expenses associated with being a public company and the liquidated damages mentioned above.

Income taxes were $269,666, compared with $65,942 in the third quarter of 2007. The increase was primarily attributable to a change in the tax exemption status of the Company's subsidiary, Heilongjiang Xing An Ling Dairy, from 100% of the prevailing tax rate in China to 50%. As a result, effective tax rate for the third quarter of 2008 was 12.5%. The Company expects that the subsidiary's tax exemption status will continue through 2010.

Net income was $808,067, or $0.03 per diluted share, in the third quarter of 2008, down from $1.4 million or $0.06 per diluted share, in the third quarter of 2007.

Balance Sheet

As of September 30, 2008, the Company had $3.7 million in cash, compared with $3.8 million as of June 30, 2008, and $7.7 million at March 31, 2008. Emerald Dairy had working capital of approximately $9.6 million as of September 30, 2008. The Company had no long term debt.

Financial Outlook

For the fiscal year 2008, the Company reiterates its revenue guidance of $42 million, or a 42% year over year increase from $29.7 million in 2007. The revenue expectation reflects demand from new distribution customers, as distributors seek out infant formula products not cited in China's recent quality control scandal, as well as the continued revenue mix shift toward higher priced products.

About Emerald Dairy Inc.:

Through its wholly-owned operating subsidiaries, Emerald Dairy Inc. is a producer and distributor of infant and children's formula, milk powder and soybean products in the People's Republic of China. The Company's products are sold under two brand names -- "Xing An Ling" and "Yi Bai."

Certain statements in this release and other written or oral statements made by or on behalf of the Company are "forward looking statements" within the meaning of the federal securities laws. Statements regarding future events and developments and our future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. The forward looking statements are subject to a number of risks and uncertainties including market acceptance of the Company's services and projects and the Company's continued access to capital and other risks and uncertainties. The actual results the Company achieves may differ materially from any forward- looking statements due to such risks and uncertainties. These statements are based on our current expectations and speak only as of the date of such statements.

Emerald Dairy Inc. and Subsidiaries Condensed Consolidated Statements of Income For the Three and Nine Months Ended September 30, 2008 and 2007 (Unaudited)

Three months ended Nine months ended September 30, September 30, September 30, September 30, 2008 2007 2008 2007

Sales $11,221,019 $8,443,361 $32,560,256 $20,971,555

Cost of Goods Sold 6,552,835 5,422,899 19,845,232 13,853,290

Gross Profit 4,668,184 3,020,462 12,715,024 7,118,265

Operating Expenses Selling and administrative expenses 3,319,484 1,561,700 10,283,634 3,985,432 Depreciation and amortization 41,905 12,999 72,336 36,844 Total operating expenses 3,361,389 1,574,699 10,355,970 4,022,276

Other Income (Expense) Interest income 2,455 965 12,061 3,597 Interest expense (231,517) (5,460) (274,923) (14,050) Total other income (expense) (229,062) (4,495) (262,862) (10,453)

Net Income Before Provision for Income Tax 1,077,733 1,441,268 2,096,192 3,085,536

Provision for Income Taxes Current 269,666 65,942 586,957 148,594 269,666 65,942 586,957 148,594

Net Income $808,067 $1,375,326 $1,509,235 $2,936,942

Basic Earnings Per Share $0.03 $0.06 $0.05 $0.12

Basic Weighted Average Shares Outstanding 29,299,332 24,305,546 29,299,332 24,305,546

Diluted Earnings Per Share $0.03 $0.06 $0.05 $0.12

Diluted Weighted Average Shares Outstanding 29,563,708 24,305,546 29,563,708 24,305,546

The Components of Other Comprehensive Income Net Income $808,067 $1,375,326 $1,509,235 $2,936,942 Foreign currency translation adjustment 259,312 165,260 1,634,624 321,927 Income tax related to other comprehensive income (88,166) (56,188) (555,772) (109,455)

Comprehensive Income $979,213 $1,484,398 $2,588,087 $3,149,414

Emerald Dairy Inc. and Subsidiaries Condensed Consolidated Balance Sheet September 30, 2008 and December 31, 2007

ASSETS 2008 2007 (Unaudited) (Audited)

Current Assets Cash and cash equivalents $3,748,746 $6,560,931 Trade accounts receivable 6,702,729 5,096,828 Inventory 1,313,621 1,000,427 Other current assets 5,444,970 3,936,751 Total current assets 17,210,066 16,594,937

Property, plant and equipment Property, plant and equipment, net 5,700,404 3,320,081 Construction in progress 2,743,133 -- 8,443,537 3,320,081

Intangible assets, net 1,384,357 115,228

$27,037,960 $20,030,246

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities Accounts and accrued expenses $4,420,313 $2,395,190 Notes payable, net of debt discount of $95,917 at September 30, 2008 2,154,083 273,973 Other current liabilities 859,308 614,977 Loan from shareholder 209,482 196,526 Total current liabilities 7,643,186 3,480,666

Put/Call Liability 3,169,444 3,169,444

Stockholders' Equity Preferred stock ($0.001 par value, 10,000,000 shares authorized, none issued and outstanding at September 30, 2008 and December 31, 2007) -- -- Common stock ($0.001 par value, 100,000,000 shares authorized, 31,243,776 issued and outstanding at September 30, 2008 and December 31, 2007) 31,244 31,241 Treasury Stock (1,944,444 shares at September 30, 2008 and December 31, 2007) (1,944) (1,944) Additional paid-in capital 4,923,348 4,666,244 Retained earnings (of which $1,340,713 and $659,903 are restricted at September 30, 2008 and December 31, 2007 for common welfare reserves) 9,301,130 7,791,895 Accumulated other comprehensive income 1,971,552 892,700 Total stockholders' equity 16,225,330 13,380,136

$27,037,960 $20,030,246

Nov 17, 2008 -- Global Med Technologies(R), Inc. ("Global Med" or "the Company") (OTCBB: GLOB), an international e-Health, medical information technology company, today announced the appointment of Karen Davis to the position of Chief Financial Officer. Ms. Davis officially assumes the position of CFO today.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

Ms. Davis brings to the Company her strong business drive and diversified experience as a CFO. Her background includes a BS in Business Administration from California State University, a CPA, 10 years in public accounting, and 15 years of CFO experience, including 8 years with public companies. Ms. Davis also has broad IR experience, having served 3 years as Director of Financial Reporting and Investor Relations for an NYSE-listed company. In addition, Ms. Davis has extensive M&A experience, as well as experience in scaling companies through organic growth and acquisition.

Ms. Davis will report directly to Mick Ruxin, M.D., Chairman and Chief Executive Officer of Global Med Technologies, Inc. In his comments about this key appointment, Dr. Ruxin stated, "As a direct result of our dramatic growth into a leading global entity in the blood supply safety arena, and our expansion into other biomedical areas, the need for a CFO with extensive knowledge in public accounting, mergers and acquisitions, sophisticated financing and investor relations became mandatory. Such a highly experienced senior executive will play a crucial role in attaining our objectives of profitable, rapid growth and moving to a listed exchange. I am extremely pleased to have an individual with the knowledge and abilities tempered by the experience of Karen Davis join our Company. Karen is a great fit for Global Med, and with her background, she will truly add value to our strategy, our processes and our management team."

Commenting on her appointment, Ms. Davis said, "I am very excited to join a dynamic growth company in a global market." Ms. Davis continued, "Also, I am particularly pleased to be a part of a creative management team that is truly making a difference in the blood bank, hospital, laboratory and biologic software industry throughout the world."

About Global Med Technologies, Inc.

Global Med Technologies(R), Inc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories.

Global Med's U.S. division, Wyndgate Technologies(R), provides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software products. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply.

Global Med's European subsidiary, Inlog, SA, is a leading provider of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog's products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and Sapa/SapaNet.

Global Med's U.S. division, eDonor(R), provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals. eDonor's products and services are designed to complement Global Med's strong line of international blood management and laboratory information software and service solutions.

Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers.

Nov. 17, 2008 -- InNexus Biotechnology Inc., (OTCBB: IXSBF/TSX VENTURE: IXS), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology, announced today that the Arizona Technology Council, in partnership with the Arizona Department of Commerce and in conjunction with Arizona Governor Janet Napolitano, named Jeff Morhet, Chairman and CEO, as the Ed Denison Business Leader of the Year at the 2008 Governor's Celebration of Innovation Awards event, which was held on 13 November 2008 at the Dodge Theatre in downtown Phoenix, Arizona.

The Ed Denison Business Leader of the Year Award is presented to an individual who contributes to Arizona's technology industry through sustained growth of their business or company. To be nominated for and receive this award, an individual must be in a leadership position employed by an Arizona-based business or division of a corporation operating in Arizona, and must have resided in Arizona for at least five years. Leadership qualities such as entrepreneurship, community involvement, and management expertise are considered.

"I'm humbled and honored to be recognized by the community and receive this year's Ed Denison Business Leader of the Year Award," said Morhet. "I am thankful for the support of my family, peers and the InNexus team, who have made this award possible. Congratulations also to the other award winners and finalists."

About the Governor's Celebration of Innovation

The Governor's Celebration of Innovation was established in 2003 by combining two technology award ceremonies: the High Tech Industry Cluster's 17-year Innovator of the Year awards ceremony and the Arizona Software and Internet Association's 10-year "Celebration of Innovation." With the addition of the Governor's support, the Governor's Celebration of Innovation has become the premier technology community gathering of its kind in Arizona.

About the Arizona Technology Council

The Arizona Technology Council is a private, not-for-profit trade association founded to connect, represent and support the state's expanding technology industry. To promote economic growth and professional development in Arizona's technology sector, the Council provides members networking opportunities, business support and access to educational forums. The Council strives to distinguish Arizona as a leader in the technology community and offer resources that are exclusive to its members. For more information, please visit http://www.aztechcouncil.org.

About InNexus

InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications. DXL antibodies utilize unique, novel and patented methods and technologies of InNexus.

InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics and diagnostics.

Nov 17, 2008 YTB International, Inc. (OTCBB: YTBLA | Quote | Chart | News | PowerRating) ("YTB" or the "Company"), a provider of Internet-based travel booking services for travel agencies and home-based independent representatives in the United States, Puerto Rico, Bermuda, the Bahamas, the U.S. Virgin Islands, and Canada, today announced its financial results for the three and nine month periods ended September 30, 2008.

Total revenue for the quarter ended September 30, 2008 increased 7.5% to $42.9 million, compared to $39.9 million for the third quarter last year. Total revenue for the nine months ended September 30, 2008 increased 36% to $130 million, compared to $96 million for the same nine-month period last year.

Net income for the third quarter of 2008 was $287,999 compared to net income of $2.1 million, for the third quarter of 2007. Net loss for the nine months ended September 30, 2008 was $3.4 million, or $0.03 per diluted share, compared to a net income of $1.6 million, or $0.01 per diluted share, for the same period of 2007.

Scott Tomer, Chief Executive Officer of YTB, commented on the third quarter results, stating, "While we are disappointed by the reduction in our net income, we are also aware that much of the softness we are seeing is reflective of both an industry-wide trend and a difficult comparison to last year's explosive growth. In the face of a looming recession, growing companies face the difficult choice of either cutting back on marketing efforts to save on expenses, or increasing these efforts in order to capture the increasingly selective customer. Our RTAs remain the lifeblood of our company, and we know that their individual business success depends on the continuous training, marketing efforts, and infrastructure that we provide. With that in mind, we have maintained a strong marketing presence, and invested in the resources and infrastructure necessary to ensure the continued success of our business."

Revenue from travel commissions and services for the quarter ended September 30, 2008 was $8 million, compared to $5.5 million for the same period last year, an increase of 45%. For the nine months ended September 30, 2008, the company received $22.2 million in revenue from travel commissions and services, compared to $13.9 million in last year's comparable period, an increase of 59%. Net cash provided by operating activities in the first nine months of 2008 was $6.1 million compared to cash provided by operating activities of $10.3 million in the first nine months of 2007.

Mr. Tomer continued, "I strongly believe that YTB's focus on affordable travel offers a needed alternative in the market place. Even with the slowing economy, we have seen a 45 percent year-over-year increase in our travel commissions for the quarter. We are confident that as the economy turns, our strategic investments in marketing and infrastructure will bear fruit."

About YTB International

YTB International, Inc. was recognized as the 26th largest seller of travel in the U.S. in Travel Weekly's 2008 Power List, based on 2007 annual retail value of travel services booked. The Company provides Internet-based travel booking services for home-based independent representatives in the United States, Puerto Rico, the Bahamas, Canada, Bermuda, and the U.S. Virgin Islands.

The Company operates through three subsidiaries: YourTravelBiz.com, Inc., YTB Travel Network, Inc., and REZconnect Technologies, Inc. YourTravelBiz.com focuses on marketing online travel websites through a nationwide network of independent business people, known as 'Reps.' YTB Travel Network establishes and maintains travel vendor relationships, processes travel transactions of online travel agents and affiliates, provides online booking systems, collects travel commissions and pays travel commissions. Each RTA directs consumers to the YTB Internet-based travel website. The REZconnect Technologies division operates a franchise chain of travel agencies and also acts as a host agency for traditional brick and mortar travel companies.

YTB International, Inc.

Condensed Consolidated Statements of Income (Unaudited)

Three months ended September 30, 2008 September 30, 2007

Total net revenues $42,876,354 $39,869,242

Operating expenses: Operating expenses (exclusive of depreciation and amortization shown below) 41,871,201 37,377,447 Depreciation and amortization 678,517 304,243

Total operating expenses 42,549,718 37,681,690

Income from operations 326,636 2,187,552

Other income (expense) Interest and dividend income 38,162 128,804 Interest expense (11,509) (23,115) Foreign currency translation loss (101,022) -

Total other income (Expense) (74,369) 105,689

Income before income tax provision (benefit) 252,267 2,293,241

Income tax provision (benefit) (35,732) 143,750

Net income $287,999 $2,149,491

Net income per share:

Weighted-average shares outstanding - basic for Class A and Class B 103,438,235 97,209,960

Weighted-average shares outstanding - diluted for Class A and Class B 110,080,692 110,801,031

Net income per share - basic for Class A and Class B (amounts for Class A and Class B shares are the same under the two-class method.) $0.00 $0.02 Net income per share

- diluted for Class A and Class B (amounts for Class A and Class B shares are the same under the two-class method.) $0.00 $0.02

YTB International, Inc.

Condensed Consolidated Statements of Income (Unaudited)

Nine months ended September 30, 2008 September 30, 2007

Total net revenues $130,378,231 $95,918,855

Operating expenses: Operating expenses (exclusive of depreciation and amortization shown below) 131,839,455 93,630,931

Depreciation and amortization 1,890,346 782,218

Total operating expenses 133,729,801 94,413,149

Income (loss) from operations (3,351,570) 1,505,706

Other income (expense):

Interest and dividend income 190,360 309,358

Interest expense (65,606) (27,041)

Foreign currency translation loss (118,625) -

Total other income (Expense) 6,129 282,317

Income (loss) before income tax provision (3,345,441) 1,788,023

Income tax provision 83,788 143,750

Net income (loss) $(3,429,229) $1,644,273

Net income (loss) per share:

Weighted-average shares outstanding - basic for Class A and Class B 103,283,879 97,143,966

Weighted-average shares outstanding - diluted for Class A and Class B 103,283,879 111,144,815

Net income (loss) per share

- basic for Class A and Class B (amounts for Class A and Class B shares are the same under the two-class method.) $(0.03) $0.02 Net income (loss) per share

- diluted for Class A and Class B (amounts for Class A and Class B shares are the same under the two-class method.) $(0.03) $0.01

YTB International, Inc.

Condensed Consolidated Balance Sheets

(Unaudited) September 30, 2008 December 31, 2007

ASSETS Current assets: Cash and cash equivalents $588,886 $1,730,570 Other current assets, net 26,251,341 39,039,546

Total current assets 26,840,227 40,770,116

Long-term investments - 1,000,000 Property and equipment, net 21,352,141 15,432,502 Intangible assets, net 2,340,080 2,395,151 Goodwill 3,128,441 2,979,322 Other assets, net 78,377 316,895

TOTAL ASSETS $53,739,266 $62,893,986

LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities $36,972,308 $44,417,965

Other long-term liabilities: Long-term debt, less current maturities 202,616 219,641 Other liabilities 928,929 947,946

Total other long-term liabilities 1,131,545 1,167,587

TOTAL LIABILITIES 38,103,853 45,585,552

TOTAL STOCKHOLDERS' EQUITY 15,635,413 17,308,434

About PennyPerformers.com

PennyPerformers.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

Penny Performers email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Penny Performers Report home page at www.PennyPerformers.com and select the "join now" button.

Join us at www.PennyPerformers.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. PennyPerformers.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyPerformers.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. PennyPerformers.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), PennyPerformers.com is owned and operated by PennyPerformers.com. Neither PennyPerformers.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since PennyPerformers.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in PennyPerformers.com statements and opinions and such statements and opinions cannot be considered independent. PennyPerformers.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. PennyPerformers.com services are often paid for using free-trading shares. PennyPerformers.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: www.PennyPerformers.com/disclaimer.htm

CONTACT: Penny Performers e-mail: info@pennyperformers.com WWW: http://www.PennyPerformers.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index